GlassScriptPhysician profile
Achin Sharma
NPI 1093715641
$12,421.98
in general payments reported to CMS, 2019-2025
50 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,629 · 2020: $2,239 · 2021: $2,172 · 2022: $1,870 · 2023: $1,374 · 2024: $1,656 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,512.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,811.23 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,245.81 | 2019-2025 | Creon, Vraylar, Ubrelvy |
| Glaxosmithkline, LLC. | $1,066.97 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $997.93 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $949.67 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $684.12 | 2019-2025 | Jardiance, Ofev |
| Abbott Laboratories | $580.24 | 2020-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Allergan, INC. | $452.24 | 2019-2022 | |
| Amarin Pharma, INC. | $451.20 | 2019-2021 | |
| Corcept Therapeutics | $419.97 | 2024-2025 | Korlym |
| Pfizer INC. | $399.66 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $309.34 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $290.70 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $262.05 | 2019-2022 | |
| Nestle Healthcare Nutrition INC. | $203.46 | 2021-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Achin Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.